Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck & Co offers greater US Januvia discounts tied to "improved health"

This article was originally published in Scrip

Executive Summary

Merck & Co has signed a deal with the US insurer Cigna whereby it will offer increased discounts on its diabetes drugs, Januvia (sitagliptin) and Janumet (sitagliptin plus metformin), if after a set period it can be shown that the health insurer's members on oral antidiabetics have improved A1c values, even if the patients are taking drugs other than Merck's.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC001735

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel